Saturday 17 October 2026
Export MLEC’s income statement to Excel — free account
Moolec Science SA
MLEC Healthcare Biotechnology
In the quarter to December 2025, revenue grew 948.4%, EPS fell 20.0% and free cash flow grew 4.48%, each against the same quarter a year earlier.
1.68
0.19
−10.16%
Follow MLEC
| Jan '20 | Jun '20 | Dec '20 | Jan '21 | Dec '21 | Jun '22 | Jan '23 | Jun '23 | Jun '24 | Jun '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | — | — | — | 3 |
P/E ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 0.14 | 0.05 |
Altman Z-Score |
— | — | — | — | — | — | 2,685.94 | 0.81 | 0.63 | (1.92) |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | — | (12.83) | (11.03) | 0.59 | (12.04) |
P/FCF ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 4.40 | 1.35 |
Beneish M-Score |
— | — | — | — | — | — | — | — | 454.43 | (7.76) |
P/Operating CF |
— | — | — | — | — | — | (477.50) | (47.62) | 1.35 | (27.58) |
P/B ratio |
— | — | — | — | — | — | 0.00 | 12.56 | 0.26 | 8.78 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 0 |
Price to Tangible BV |
— | — | — | — | — | — | 0.00 | 95.03 | 0.00 | 0.00 |
EV/Sales |
— | — | — | — | — | — | 0.00 | 0.00 | 0.96 | 0.10 |
EV/EBITDA |
— | — | — | — | — | — | 0.00 | 0.00 | 12.04 | 1.19 |
EV/Operating CF |
— | — | — | — | — | — | (192.04) | (16.87) | 11.32 | 1.03 |
EV/FCF |
— | — | — | — | — | — | (192.04) | (16.87) | 30.45 | 2.46 |
Quick Ratio |
0.02 | — | 0.02 | 0.12 | 0.12 | 0.26 | 0.36 | 0.36 | 0.73 | 0.12 |
Current Ratio |
0.02 | — | 1.04 | 0.14 | 0.14 | 0.27 | 0.42 | 0.42 | 1.03 | 0.13 |
Net Debt/EBITDA |
(20.93) | 0.00 | (8.62) | 0.01 | 0.01 | 0.30 | 0.03 | 0.03 | 10.30 | (2.73) |
Debt/Assets |
94.43% | 0.00% | 40.01% | 0.09% | 0.09% | 0.00% | 11.00% | 11.00% | 47.45% | 120.54% |
Debt/Equity |
23.79 | — | 10.08 | 0.00 | (0.04) | 0.00 | 0.26 | 0.26 | 1.80 | (2.98) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.96 | 0.58 |
Operating CF/Net income |
0.64 | (0.36) | 0.64 | 9.76 | 9.76 | 0.42 | 0.15 | 0.15 | (1.21) | (0.03) |
Capex/Depreciation |
— | 0.00 | — | — | — | 0.00 | 0.00 | (1.47) | (1.38) | (0.83) |
Interest Coverage |
— | — | — | 0.00 | — | (1,739.24) | (18.94) | (41.59) | 0.51 | (2.49) |
| (111.29%) | 0.00% | (111.29%) | 0.00% | 5.99% | 587.91% | 0.00% | (884.51%) | (25.13%) | (133.38%) | |
| (8.83%) | (4.46%) | (4.46%) | 0.00% | (0.14%) | (6.29%) | 0.00% | (348.24%) | (6.71%) | (19.31%) | |
ROIC |
0.00% | 0.00% | (6.57%) | 0.00% | 0.00% | (436.89%) | 0.00% | (41.93%) | 1.90% | (42.03%) |
Return on Tangible Assets |
4.70% | 0.00% | (111.29%) | 9.78% | 9.78% | 151.17% | 851.58% | 845.49% | (38.27%) | 55.31% |
Average Days of Receivables |
— | — | — | — | — | — | 682.13 | 682.13 | 191.21 | 21.81 |
Research and Development Expense of Revenue |
— | 0.00% | — | — | — | 0.00% | 149.12% | 149.30% | 3.74% | 4.54% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | — | 0.00% | — | 0.00% | 548.97% | 559.68% | 27.09% | 37.74% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.81 | 0.36 | 0.36 | 0.30 | 0.37 |
Share Based Compensation of Revenue |
— | — | — | — | — | 0.00% | 0.00% | 4,839.80% | 3.04% | 1.31% |
Graham Net Nets |
— | — | — | — | — | — | (0.11) | (0.07) | (4.05) | (0.78) |
Graham Number |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | — | (17.62%) | (40.81%) | (45.27%) | (82.94%) |
Free Cash Flow Yield |
— | — | — | — | — | — | (0.52%) | (5.92%) | 22.74% | 73.86% |
Revenue per Share |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 3.94 | 1,201.07 | 773.86 |
Operating CF per Share |
0.00 | 0.00 | (0.43) | (0.05) | (38.61) | (9.12) | (0.22) | (32.67) | 101.87 | 8.44 |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.78) | (63.58) | (33.00) |
Free Cash Flow per Share |
0.00 | 0.00 | (0.43) | (0.05) | (38.61) | (9.12) | (0.22) | (33.45) | 38.29 | (24.57) |
Cash per Share |
0.00 | — | 0.29 | 0.01 | 5.79 | 5.23 | 0.08 | 12.33 | 174.25 | 20.93 |
Shareholders Equity per Share |
0.00 | — | 0.60 | 7.76 | (132.67) | 7.76 | 0.29 | 43.96 | 643.84 | (192.24) |
Interest Debt per Share |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | — | 0.60 | 7.76 | (132.67) | 7.76 | 0.29 | 43.96 | 643.84 | (192.24) |
Free Cash Flow |
(0.01) | 0.01 | (0.01) | (0.92) | (0.92) | (1.89) | (7.54) | (7.69) | 14.87 | (10.59) |
Working Capital |
(0.29) | — | 0.01 | (0.96) | (0.96) | (3.00) | (7.27) | (7.27) | 10.80 | (204.86) |
Capital Expenditures |
— | 0.00 | — | — | — | — | (0.18) | (0.18) | (24.69) | (14.23) |
Net Current Asset Value |
(0.29) | — | 0.01 | (3.16) | (141.16) | (3.00) | (8.61) | (8.61) | (261.63) | (256.39) |
EV/EBIT |
— | — | — | — | — | — | 0.00 | 0.00 | 23.22 | 2.32 |
Capex to Sales |
— | 0.00 | — | — | — | — | 0.00 | 0.20 | 0.05 | 0.04 |
Price to Operating Income |
— | — | — | — | — | — | 0.00 | 0.00 | 3.35 | 1.28 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | 0.00 | — | — | — | 0.19 | 0.10 | 0.11 | 0.24 | 5.15 |
Cash ROIC |
(2.81%) | 0.00% | (6.13%) | (0.68%) | 31.75% | (70.21%) | (48.35%) | (49.35%) | 1.94% | (6.12%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | 0.00 | 0.54 | 3.79 | 2.52 |
Accounts Payable Turnover |
— | — | — | — | — | — | 0.00 | 0.24 | 3.17 | 2.31 |
Inventory Turnover |
— | — | — | — | — | — | 0.00 | 2.25 | 4.41 | 3.17 |
Average Days of Payables |
— | — | — | — | — | 0.00 | 1,045.57 | 2,604.02 | 220.72 | 13.14 |
Days of Inventory on Hand |
— | — | — | — | — | — | 156.39 | 162.13 | 164.91 | 4.01 |
Average Receivables |
— | — | — | — | — | — | — | 1.69 | 123.01 | 132.13 |
Average Payables |
— | — | — | — | — | — | 2.17 | 4.35 | 88.21 | 88.13 |
Average Inventory |
— | — | — | — | — | — | — | 0.47 | 63.34 | 64.23 |
Average Assets |
0.16 | 0.31 | 0.31 | 69.24 | 69.24 | 71.93 | 14.87 | 14.87 | 486.94 | 577.27 |
Average Common Equity |
0.01 | — | 0.01 | 67.43 | (1.57) | (0.77) | 5.86 | 5.86 | 130.05 | 83.56 |
Columns are period end dates